Delivery Order SPE2DB24D2101-SPE2DB25FKQBX
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 60 tablets of Eliquis 2.5 mg, a widely-used anticoagulant medication. The delivery order, valued at $1,965.60 with a firm fixed price, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. This award represents a competitive, non-set-aside transaction and will be performed at the...
- The Defense Logistics Agency awarded a delivery order valued at $1,228.50 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a commonly prescribed anticoagulant medication. This non-set-aside, competitively awarded contract was issued on September 9, 2025, with an ultimate completion date of September 10, 2025, and utilizes firm fixed pricing. The contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $1,719.90 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg on July 24, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,572.66 for 60 tablets of Eliquis 5 mg, a common anticoagulant medication. This non-competitive, firm fixed-price delivery order was awarded on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,965.60 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by June 2, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,620.03 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages). This non-set-aside, firm fixed-price delivery order was awarded on September 10, 2025, with an ultimate completion date of September 11, 2025. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters and primary operations. This delivery order is a child...
- The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Eliquis 2.5 mg, a widely used anticoagulant medication. This non-competitive delivery order, issued on April 22, 2025, with an ultimate completion date of April 23, 2025, operates under a firm fixed-price arrangement and represents a single-line pharmaceutical procurement to support federal medical supply needs. The award is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $30,692.41 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, and carries firm fixed pricing with no set-aside designation. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a commonly prescribed anticoagulant medication, under a firm fixed-price contract valued at $1,474.20. The award was made on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a non-set-aside competitive award. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $15,763.14 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, with no set-aside designation applied. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, served as the prime contractor for this pharmaceutical delivery. This contract represents a...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKQBXDelivery Order
The Defense Logistics Agency awarded a $3,931.20 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a widely-used anticoagulant medication. The contract, designated as a firm fixed price delivery order without set-aside provisions, is scheduled for completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award represents a child contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's $1 billion prime IDC with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support vehicle enabling supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order exemplifies AmerisourceBergen's role in the Defense Health Agency's pharmaceutical supply chain, fulfilling routine medication requirements through competitive procurement mechanisms that position the company as a qualified federal healthcare vendor.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/26/25 |